Iloprost 20 mcg/mL
| Product Overview | |
| Generic Name | Iloprost 20 mcg/mL |
| Brand Name(s) | Ventavis, Ilomedine, Aurlumyn |
| Form | Inhalation solution (ampules) for nebulizer |
| Strength | 20 µg/mL concentration in 1 mL ampules |
| Therapeutic Class | Vasodilator; platelet aggregation inhibitor |
| ATC Code | B01AC11 |
| Manufacturing & Regulatory | |
| Manufacturer | Bayer/Actelion (originator); biosimilars Mex/India |
| Country | Germany, Switzerland, India |
| GMP Compliance | WHO‑GMP |
| DMF/CEP | biosimilars hold Type II DMFs (finished dosage) |
| COFEPRIS | Registered in Mexico 335M2006SSAIV – Ventavis inhalation solution |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 25 |
| Shelf Life | 24 Months |
| Storage | 2–8 °C; protect from light; do not freeze |
| Incoterms | FOB / CIF / DDP standard |
| Lead Time | 7 to 10 Days |
| Documentation | |
| Certificate of Analysis (COA) | Provided by manufacturer/distributor |
| SDS | Yes – inhaled prostacyclin handling (aerosolized drug safety) |
| CTD Summary | Yes, (proprietary; request upon commercial interest) |
Description
INDICATIONS & USAGE: Inhaled prostacyclin used for WHO Group 1 PAH, improves exercise tolerance and symptoms
